Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
PUT
DigitalBridge
DBRG
$2.94B
| $2.68M | ﹤0.01% |
237,300
-39,000
| -14% | -$524K |
|
5002
Inter&Co
INTR
$2.29B
| $2.68M | ﹤0.01% |
634,200
+600,983
| +1,809% | +$3.37M |
|
|
EB
5003
DELISTED
Eventbrite
EB
| $2.68M | ﹤0.01% |
796,397
+330,045
| +71% | +$1.09M |
|
5004
CALL
Deutsche Bank
DB
$72.5B
| $2.68M | ﹤0.01% |
156,900
-119,700
| -43% | -$2.06M |
|
5005
Wabash National
WNC
$512M
| $2.67M | ﹤0.01% |
156,045
-324,885
| -68% | -$6.02M |
|
|
ITCI
5006
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.67M | ﹤0.01% |
32,000
-8,500
| -21% | -$698K |
|
5007
PUT
Regions Financial
RF
$27.2B
| $2.67M | ﹤0.01% |
113,600
-1,000
| -0.9% | -$24.7K |
|
5008
iShares MSCI Spain ETF
EWP
$2.22B
| $2.67M | ﹤0.01% |
+86,044
| New | +$2.85M |
|
|
CBNA
5009
Chain Bridge Bancorp
CBNA
$307M
| $2.67M | ﹤0.01% |
+106,566
| New | +$2.51M |
|
5010
PUT
NewAmsterdam Pharma
NAMS
$3.23B
| $2.67M | ﹤0.01% |
103,900
+100,300
| +2,786% | +$2.13M |
|
5011
PUT
Black Stone Minerals
BSM
$3.05B
| $2.67M | ﹤0.01% |
182,700
+41,600
| +29% | +$620K |
|
5012
iShares Future Exponential Technologies ETF
XT
$3.99B
| $2.67M | ﹤0.01% |
44,671
+26,380
| +144% | +$1.6M |
|
5013
Cerus
CERS
$601M
| $2.66M | ﹤0.01% |
1,729,505
+667,514
| +63% | +$1.15M |
|
|
GOLD
5014
CALL
Gold.com Inc
GOLD
$1.28B
| $2.66M | ﹤0.01% |
97,200
+15,300
| +19% | +$519K |
|
5015
Movado Group
MOV
$803M
| $2.66M | ﹤0.01% |
135,124
-354,255
| -72% | -$6.94M |
|
5016
CALL
NEOS S&P 500 High Income ETF
SPYI
$11.5B
| $2.66M | ﹤0.01% |
52,300
+25,200
| +93% | +$1.31M |
|
5017
iShares MSCI Emerging Markets Asia ETF
EEMA
$870M
| $2.66M | ﹤0.01% |
37,072
-138,592
| -79% | -$10.5M |
|
5018
CALL
Royalty Pharma
RPRX
$26.1B
| $2.66M | ﹤0.01% |
104,100
+18,000
| +21% | +$477K |
|
5019
CALL
Sonos
SONO
$1.93B
| $2.65M | ﹤0.01% |
176,500
-58,700
| -25% | -$790K |
|
5020
Digimarc Corp
DMRC
$169M
| $2.65M | ﹤0.01% |
70,867
+4,295
| +6% | +$140K |
|
5021
TXO Partners LP
TXO
$766M
| $2.65M | ﹤0.01% |
157,559
+80,277
| +104% | +$1.46M |
|
5022
Mercury Insurance
MCY
$5.84B
| $2.65M | ﹤0.01% |
+39,910
| New | +$2.81M |
|
5023
CALL
Lightspeed Commerce
LSPD
$1.38B
| $2.65M | ﹤0.01% |
174,200
+28,700
| +20% | +$471K |
|
5024
CALL
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $2.65M | ﹤0.01% |
53,100
+16,400
| +45% | +$807K |
|
5025
Celsius Holdings
CELH
$7.36B
| $2.65M | ﹤0.01% |
100,529
-303,303
| -75% | -$9M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.